Alexis Caulier, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Anemia, Hemolytic, Congenital | 3 | 2022 | 71 | 1.590 |
Why?
|
Erythropoiesis | 7 | 2024 | 694 | 1.420 |
Why?
|
Ion Channels | 4 | 2024 | 1044 | 0.780 |
Why?
|
Erythrocyte Volume | 1 | 2018 | 28 | 0.620 |
Why?
|
Water-Electrolyte Imbalance | 1 | 2018 | 110 | 0.560 |
Why?
|
Mechanotransduction, Cellular | 1 | 2022 | 542 | 0.540 |
Why?
|
Erythroid Precursor Cells | 1 | 2017 | 212 | 0.540 |
Why?
|
Hematopoietic Stem Cell Transplantation | 7 | 2022 | 5709 | 0.430 |
Why?
|
Graft vs Host Disease | 3 | 2022 | 3042 | 0.420 |
Why?
|
Myelodysplastic Syndromes | 2 | 2023 | 1400 | 0.410 |
Why?
|
Erythrocytes | 1 | 2022 | 2422 | 0.410 |
Why?
|
Erythrocyte Transfusion | 1 | 2017 | 574 | 0.400 |
Why?
|
France | 3 | 2021 | 497 | 0.360 |
Why?
|
Hydrops Fetalis | 2 | 2021 | 113 | 0.340 |
Why?
|
Hematopoietic Stem Cells | 6 | 2024 | 3408 | 0.310 |
Why?
|
Multiple Myeloma | 4 | 2021 | 5192 | 0.300 |
Why?
|
GATA1 Transcription Factor | 2 | 2024 | 307 | 0.260 |
Why?
|
Erythroblasts | 2 | 2020 | 142 | 0.220 |
Why?
|
Anemia, Diamond-Blackfan | 1 | 2024 | 147 | 0.220 |
Why?
|
14-3-3 Proteins | 1 | 2022 | 222 | 0.190 |
Why?
|
Hematopoiesis | 3 | 2024 | 2058 | 0.170 |
Why?
|
Leukemia, Erythroblastic, Acute | 1 | 2020 | 176 | 0.170 |
Why?
|
Immunoglobulin Heavy Chains | 2 | 2020 | 648 | 0.170 |
Why?
|
Chimerism | 1 | 2020 | 156 | 0.170 |
Why?
|
Leukoencephalopathy, Progressive Multifocal | 1 | 2020 | 133 | 0.170 |
Why?
|
RNA Polymerase II | 1 | 2023 | 547 | 0.160 |
Why?
|
Paraproteinemias | 1 | 2021 | 254 | 0.160 |
Why?
|
Cytarabine | 1 | 2021 | 697 | 0.160 |
Why?
|
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2020 | 230 | 0.150 |
Why?
|
Transplantation, Autologous | 2 | 2021 | 2126 | 0.150 |
Why?
|
Artificial Intelligence | 2 | 2023 | 2659 | 0.150 |
Why?
|
Anemia, Hemolytic | 1 | 2018 | 164 | 0.140 |
Why?
|
Ion Transport | 1 | 2018 | 322 | 0.140 |
Why?
|
Mice, Inbred NOD | 2 | 2020 | 1839 | 0.140 |
Why?
|
Gene Expression Regulation | 3 | 2024 | 11930 | 0.140 |
Why?
|
Potassium | 1 | 2021 | 1319 | 0.140 |
Why?
|
Leukemia, Myeloid, Acute | 2 | 2024 | 3623 | 0.130 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2022 | 616 | 0.130 |
Why?
|
Cytomegalovirus Infections | 1 | 2022 | 839 | 0.130 |
Why?
|
Cell Line, Transformed | 1 | 2017 | 868 | 0.130 |
Why?
|
Hemoglobins | 1 | 2022 | 1532 | 0.130 |
Why?
|
Sodium | 1 | 2021 | 1595 | 0.130 |
Why?
|
Gene Rearrangement | 1 | 2020 | 1139 | 0.120 |
Why?
|
Antigens, CD34 | 1 | 2017 | 656 | 0.120 |
Why?
|
Cell Lineage | 1 | 2024 | 2575 | 0.120 |
Why?
|
Flow Cytometry | 2 | 2023 | 5904 | 0.120 |
Why?
|
Triage | 1 | 2021 | 997 | 0.110 |
Why?
|
Transgenes | 1 | 2017 | 1015 | 0.110 |
Why?
|
Cell Differentiation | 5 | 2024 | 11674 | 0.110 |
Why?
|
Patient Transfer | 1 | 2021 | 796 | 0.110 |
Why?
|
Mice, SCID | 1 | 2017 | 2633 | 0.100 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 3 | 2021 | 11843 | 0.100 |
Why?
|
Humans | 27 | 2024 | 768451 | 0.100 |
Why?
|
Transplantation Conditioning | 1 | 2018 | 1598 | 0.100 |
Why?
|
Oncogenes | 1 | 2017 | 1235 | 0.090 |
Why?
|
Immunotherapy, Adoptive | 1 | 2020 | 1505 | 0.090 |
Why?
|
Cell Culture Techniques | 1 | 2017 | 1669 | 0.080 |
Why?
|
Transplantation, Homologous | 1 | 2018 | 4834 | 0.080 |
Why?
|
Health Services Needs and Demand | 1 | 2017 | 1408 | 0.080 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2020 | 1644 | 0.080 |
Why?
|
Cell Nucleus | 1 | 2017 | 2889 | 0.080 |
Why?
|
Neoplasm Proteins | 1 | 2020 | 3611 | 0.080 |
Why?
|
Stem Cells | 1 | 2019 | 3538 | 0.070 |
Why?
|
Research Design | 2 | 2021 | 6217 | 0.070 |
Why?
|
Waldenstrom Macroglobulinemia | 1 | 2015 | 1077 | 0.070 |
Why?
|
Survival Analysis | 1 | 2018 | 10125 | 0.060 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2017 | 1890 | 0.060 |
Why?
|
Age Factors | 1 | 2021 | 18478 | 0.060 |
Why?
|
Kidney Diseases | 1 | 2015 | 2102 | 0.060 |
Why?
|
Follow-Up Studies | 3 | 2021 | 39430 | 0.060 |
Why?
|
Treatment Outcome | 2 | 2021 | 65409 | 0.050 |
Why?
|
Prognosis | 3 | 2021 | 30028 | 0.050 |
Why?
|
Mice | 5 | 2024 | 82045 | 0.050 |
Why?
|
Transcriptional Elongation Factors | 1 | 2023 | 167 | 0.050 |
Why?
|
Single-Cell Analysis | 2 | 2024 | 2531 | 0.050 |
Why?
|
Electrophoresis | 1 | 2021 | 226 | 0.050 |
Why?
|
Lentivirus | 1 | 2024 | 519 | 0.050 |
Why?
|
Retrospective Studies | 8 | 2022 | 81834 | 0.050 |
Why?
|
Daunorubicin | 1 | 2021 | 157 | 0.050 |
Why?
|
Transcription Factors | 1 | 2020 | 12174 | 0.040 |
Why?
|
Radiation Chimera | 1 | 2020 | 216 | 0.040 |
Why?
|
Young Adult | 3 | 2021 | 60045 | 0.040 |
Why?
|
Adult | 5 | 2021 | 223542 | 0.040 |
Why?
|
Clone Cells | 1 | 2024 | 1672 | 0.040 |
Why?
|
Leukapheresis | 1 | 2020 | 150 | 0.040 |
Why?
|
Hydroxamic Acids | 1 | 2022 | 482 | 0.040 |
Why?
|
Transcription, Genetic | 2 | 2024 | 7599 | 0.040 |
Why?
|
Monoclonal Gammopathy of Undetermined Significance | 1 | 2021 | 179 | 0.040 |
Why?
|
Signal Transduction | 1 | 2022 | 23638 | 0.040 |
Why?
|
Janus Kinase 2 | 1 | 2022 | 561 | 0.040 |
Why?
|
Cohort Studies | 2 | 2021 | 41797 | 0.040 |
Why?
|
Blood Chemical Analysis | 1 | 2021 | 436 | 0.040 |
Why?
|
Gene Knock-In Techniques | 1 | 2020 | 423 | 0.040 |
Why?
|
Thalidomide | 2 | 2015 | 885 | 0.040 |
Why?
|
Female | 8 | 2021 | 396943 | 0.040 |
Why?
|
DNA, Mitochondrial | 1 | 2024 | 871 | 0.040 |
Why?
|
Male | 7 | 2021 | 364781 | 0.040 |
Why?
|
Cytomegalovirus | 1 | 2022 | 755 | 0.040 |
Why?
|
Histone Deacetylases | 1 | 2022 | 717 | 0.040 |
Why?
|
Transplantation Chimera | 1 | 2020 | 594 | 0.040 |
Why?
|
Dioxygenases | 1 | 2020 | 351 | 0.040 |
Why?
|
Animals | 5 | 2024 | 169418 | 0.040 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2022 | 776 | 0.040 |
Why?
|
Antigens, CD19 | 1 | 2020 | 437 | 0.040 |
Why?
|
Genetic Engineering | 1 | 2023 | 936 | 0.040 |
Why?
|
Herpesvirus 4, Human | 1 | 2022 | 1081 | 0.030 |
Why?
|
Genetic Heterogeneity | 1 | 2020 | 738 | 0.030 |
Why?
|
Dexamethasone | 2 | 2015 | 1965 | 0.030 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2021 | 712 | 0.030 |
Why?
|
Death | 1 | 2021 | 683 | 0.030 |
Why?
|
Cell Division | 1 | 2024 | 4479 | 0.030 |
Why?
|
Aged | 5 | 2021 | 171520 | 0.030 |
Why?
|
Netherlands | 1 | 2020 | 2274 | 0.030 |
Why?
|
Glomerular Basement Membrane | 1 | 2015 | 35 | 0.030 |
Why?
|
Middle Aged | 6 | 2021 | 223418 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2020 | 1869 | 0.030 |
Why?
|
Congresses as Topic | 1 | 2020 | 810 | 0.030 |
Why?
|
Canada | 1 | 2020 | 2143 | 0.030 |
Why?
|
Neoplasm, Residual | 1 | 2020 | 1014 | 0.030 |
Why?
|
Cell Cycle | 1 | 2023 | 2942 | 0.030 |
Why?
|
Genetic Vectors | 1 | 2024 | 3417 | 0.030 |
Why?
|
Genome | 1 | 2023 | 1749 | 0.030 |
Why?
|
Immunoglobulin Light Chains | 1 | 2015 | 289 | 0.030 |
Why?
|
HIV Infections | 1 | 2020 | 17564 | 0.030 |
Why?
|
Chromosome Aberrations | 1 | 2020 | 1781 | 0.030 |
Why?
|
Neoplastic Stem Cells | 1 | 2020 | 1357 | 0.030 |
Why?
|
Proteinuria | 1 | 2015 | 613 | 0.020 |
Why?
|
Chromatin | 1 | 2024 | 2969 | 0.020 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2020 | 2568 | 0.020 |
Why?
|
Biological Products | 1 | 2020 | 937 | 0.020 |
Why?
|
Disease Progression | 2 | 2020 | 13655 | 0.020 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2020 | 2847 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2024 | 3939 | 0.020 |
Why?
|
Bone Marrow | 1 | 2020 | 2929 | 0.020 |
Why?
|
Survival Rate | 2 | 2015 | 12875 | 0.020 |
Why?
|
Alleles | 1 | 2020 | 6890 | 0.020 |
Why?
|
Cyclophosphamide | 1 | 2015 | 2224 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2020 | 2987 | 0.020 |
Why?
|
Boronic Acids | 1 | 2013 | 915 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2023 | 5808 | 0.020 |
Why?
|
Biopsy | 1 | 2020 | 6816 | 0.020 |
Why?
|
Societies, Medical | 1 | 2020 | 3955 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2024 | 10494 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 1 | 2020 | 4534 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2020 | 3665 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2020 | 9558 | 0.020 |
Why?
|
Mutation | 2 | 2024 | 30243 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2021 | 3805 | 0.020 |
Why?
|
Pyrazines | 1 | 2013 | 1206 | 0.020 |
Why?
|
Remission Induction | 1 | 2013 | 2408 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2024 | 17149 | 0.020 |
Why?
|
Hospital Mortality | 1 | 2021 | 5371 | 0.020 |
Why?
|
Glomerular Filtration Rate | 1 | 2015 | 2226 | 0.020 |
Why?
|
Aging | 1 | 2024 | 8761 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2021 | 9425 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2020 | 9623 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2021 | 15965 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2020 | 22365 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2013 | 8559 | 0.010 |
Why?
|
Hospitalization | 1 | 2020 | 10845 | 0.010 |
Why?
|
Risk Assessment | 1 | 2021 | 24311 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2013 | 11249 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2021 | 59680 | 0.010 |
Why?
|
Brain | 1 | 2020 | 27438 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2020 | 36840 | 0.010 |
Why?
|